BeOne Medicines Ltd. (ONC) › Capital ExpendituresBeOne Medicines Ltd. (ONC) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $654.0K2015: $5.31M2016: $23.50M2017: $46.37M2018: $70.28M2019: $89.61M2020: $117.51M2021: $262.94M2022: $325.43M2023: $561.90M2024: $492.66M2025: $185.84M$185.84M2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$185.84M-62.3%2024$492.66M-12.3%2023$561.90M+72.7%2022$325.43M+23.8%2021$262.94M+123.8%2020$117.51M+31.1%2019$89.61M+27.5%2018$70.28M+51.6%2017$46.37M+97.3%2016$23.50M+342.3%2015$5.31M+712.5%2014$654.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share